$GYHT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HALOZYME THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HALOZYME THERAPEUTICS, INC.. Get notifications about new insider transactions in HALOZYME THERAPEUTICS, INC. for free.
Page: < prev 1 ... 7 8 9 10 11 12 13 14 15 ... 15 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 10.12 | 866 | 8,764 | 382,610 | 383.5 K to 382.6 K (-0.23 %) |
Jun 15 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 10.11 | 1,600 | 16,176 | 383,476 | 385.1 K to 383.5 K (-0.42 %) |
Jun 15 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 10.10 | 1,834 | 18,523 | 385,076 | 386.9 K to 385.1 K (-0.47 %) |
Jun 15 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 10.09 | 400 | 4,037 | 386,910 | 387.3 K to 386.9 K (-0.10 %) |
Jun 15 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 10.09 | 2,200 | 22,198 | 387,310 | 389.5 K to 387.3 K (-0.56 %) |
Jun 15 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 10.08 | 900 | 9,072 | 389,510 | 390.4 K to 389.5 K (-0.23 %) |
Jun 15 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 10.07 | 800 | 8,056 | 390,410 | 391.2 K to 390.4 K (-0.20 %) |
Jun 15 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 10.06 | 200 | 2,012 | 391,210 | 391.4 K to 391.2 K (-0.05 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.20 | 100 | 1,020 | 152,471 | 152.6 K to 152.5 K (-0.07 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.19 | 400 | 4,076 | 152,571 | 153 K to 152.6 K (-0.26 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.18 | 500 | 5,090 | 152,971 | 153.5 K to 153 K (-0.33 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.15 | 100 | 1,015 | 153,471 | 153.6 K to 153.5 K (-0.07 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.14 | 100 | 1,014 | 153,571 | 153.7 K to 153.6 K (-0.07 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.13 | 200 | 2,026 | 153,671 | 153.9 K to 153.7 K (-0.13 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.12 | 500 | 5,060 | 153,871 | 154.4 K to 153.9 K (-0.32 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.11 | 300 | 3,033 | 154,371 | 154.7 K to 154.4 K (-0.19 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.10 | 700 | 7,070 | 154,671 | 155.4 K to 154.7 K (-0.45 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.09 | 100 | 1,009 | 155,371 | 155.5 K to 155.4 K (-0.06 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.08 | 300 | 3,024 | 155,471 | 155.8 K to 155.5 K (-0.19 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.07 | 700 | 7,049 | 155,771 | 156.5 K to 155.8 K (-0.45 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.06 | 1,700 | 17,102 | 156,471 | 158.2 K to 156.5 K (-1.07 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.05 | 2,600 | 26,130 | 158,171 | 160.8 K to 158.2 K (-1.62 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.04 | 3,000 | 30,120 | 160,771 | 163.8 K to 160.8 K (-1.83 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.03 | 1,781 | 17,863 | 163,771 | 165.6 K to 163.8 K (-1.08 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.02 | 1,419 | 14,218 | 165,552 | 167 K to 165.6 K (-0.85 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.01 | 3,700 | 37,037 | 166,971 | 170.7 K to 167 K (-2.17 %) |
Jun 14 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.00 | 1,800 | 18,000 | 170,671 | 172.5 K to 170.7 K (-1.04 %) |
Jun 13 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.45 | 22,241 | 10,000 | 1,130,242 | |
Jun 13 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 20,896 | 8,985 | 1,152,483 | |
Jun 13 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 10.02 | 896 | 8,978 | 2,929,606 | 2.9 M to 2.9 M (-0.03 %) |
Jun 13 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.45 | 22,241 | 10,000 | 2,930,502 | 2.9 M to 2.9 M (+0.76 %) |
Jun 13 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 20,896 | 8,985 | 2,908,261 | 2.9 M to 2.9 M (+0.72 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 20,853 | 8,967 | 1,173,379 | |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.55 | 100 | 1,055 | 2,077,365 | 2.1 M to 2.1 M (0.00 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.54 | 600 | 6,324 | 2,077,465 | 2.1 M to 2.1 M (-0.03 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.53 | 1,000 | 10,530 | 2,078,065 | 2.1 M to 2.1 M (-0.05 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.52 | 3,500 | 36,820 | 2,079,065 | 2.1 M to 2.1 M (-0.17 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.51 | 1,300 | 13,663 | 2,082,565 | 2.1 M to 2.1 M (-0.06 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.50 | 6,200 | 65,100 | 2,083,865 | 2.1 M to 2.1 M (-0.30 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.49 | 1,900 | 19,931 | 2,090,065 | 2.1 M to 2.1 M (-0.09 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.48 | 600 | 6,288 | 2,091,965 | 2.1 M to 2.1 M (-0.03 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.47 | 1,000 | 10,470 | 2,092,565 | 2.1 M to 2.1 M (-0.05 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.46 | 200 | 2,092 | 2,093,565 | 2.1 M to 2.1 M (-0.01 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.43 | 100 | 1,043 | 2,093,765 | 2.1 M to 2.1 M (0.00 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.41 | 200 | 2,082 | 2,093,865 | 2.1 M to 2.1 M (-0.01 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.38 | 600 | 6,228 | 2,094,065 | 2.1 M to 2.1 M (-0.03 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.35 | 100 | 1,035 | 2,094,665 | 2.1 M to 2.1 M (0.00 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.34 | 200 | 2,068 | 2,094,765 | 2.1 M to 2.1 M (-0.01 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.33 | 700 | 7,231 | 2,094,965 | 2.1 M to 2.1 M (-0.03 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.32 | 600 | 6,192 | 2,095,665 | 2.1 M to 2.1 M (-0.03 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.31 | 500 | 5,155 | 2,096,265 | 2.1 M to 2.1 M (-0.02 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.30 | 600 | 6,180 | 2,096,765 | 2.1 M to 2.1 M (-0.03 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 10.51 | 853 | 8,965 | 2,097,365 | 2.1 M to 2.1 M (-0.04 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 20,853 | 8,967 | 2,098,218 | 2.1 M to 2.1 M (+1.00 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 20,849 | 8,965 | 1,194,232 | |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.77 | 600 | 6,462 | 2,077,365 | 2.1 M to 2.1 M (-0.03 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.72 | 3 | 32 | 2,077,965 | 2.1 M to 2.1 M (0.00 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.70 | 300 | 3,210 | 2,077,968 | 2.1 M to 2.1 M (-0.01 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.67 | 800 | 8,536 | 2,078,268 | 2.1 M to 2.1 M (-0.04 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.66 | 100 | 1,066 | 2,079,068 | 2.1 M to 2.1 M (0.00 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.63 | 100 | 1,063 | 2,079,168 | 2.1 M to 2.1 M (0.00 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.62 | 200 | 2,124 | 2,079,268 | 2.1 M to 2.1 M (-0.01 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.60 | 442 | 4,685 | 2,079,468 | 2.1 M to 2.1 M (-0.02 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.59 | 2,200 | 23,298 | 2,079,910 | 2.1 M to 2.1 M (-0.11 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.58 | 3,453 | 36,533 | 2,082,110 | 2.1 M to 2.1 M (-0.17 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.57 | 2,403 | 25,400 | 2,085,563 | 2.1 M to 2.1 M (-0.12 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.56 | 1,102 | 11,637 | 2,087,966 | 2.1 M to 2.1 M (-0.05 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.55 | 2,097 | 22,123 | 2,089,068 | 2.1 M to 2.1 M (-0.10 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.54 | 3,100 | 32,674 | 2,091,165 | 2.1 M to 2.1 M (-0.15 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.53 | 1,400 | 14,742 | 2,094,265 | 2.1 M to 2.1 M (-0.07 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.52 | 500 | 5,260 | 2,095,665 | 2.1 M to 2.1 M (-0.02 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.51 | 1,000 | 10,510 | 2,096,165 | 2.1 M to 2.1 M (-0.05 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 10.50 | 200 | 2,100 | 2,097,165 | 2.1 M to 2.1 M (-0.01 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Gift | G | 0.00 | 20,000 | 0 | 2,097,365 | 2.1 M to 2.1 M (-0.94 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 10.55 | 849 | 8,957 | 2,117,365 | 2.1 M to 2.1 M (-0.04 %) |
Jun 08 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 20,849 | 8,965 | 2,118,214 | 2.1 M to 2.1 M (+0.99 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.72 | 100 | 1,072 | 576,997 | 577.1 K to 577 K (-0.02 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.70 | 200 | 2,140 | 577,097 | 577.3 K to 577.1 K (-0.03 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.69 | 200 | 2,138 | 577,297 | 577.5 K to 577.3 K (-0.03 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.68 | 100 | 1,068 | 577,497 | 577.6 K to 577.5 K (-0.02 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.67 | 200 | 2,134 | 577,597 | 577.8 K to 577.6 K (-0.03 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.66 | 300 | 3,198 | 577,797 | 578.1 K to 577.8 K (-0.05 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.64 | 300 | 3,192 | 578,097 | 578.4 K to 578.1 K (-0.05 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.63 | 100 | 1,063 | 578,397 | 578.5 K to 578.4 K (-0.02 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.62 | 400 | 4,248 | 578,497 | 578.9 K to 578.5 K (-0.07 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.61 | 400 | 4,244 | 578,897 | 579.3 K to 578.9 K (-0.07 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.58 | 200 | 2,116 | 579,297 | 579.5 K to 579.3 K (-0.03 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.57 | 1,137 | 12,018 | 579,497 | 580.6 K to 579.5 K (-0.20 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.56 | 463 | 4,889 | 580,634 | 581.1 K to 580.6 K (-0.08 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.55 | 300 | 3,165 | 581,097 | 581.4 K to 581.1 K (-0.05 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.54 | 200 | 2,108 | 581,397 | 581.6 K to 581.4 K (-0.03 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.53 | 200 | 2,106 | 581,597 | 581.8 K to 581.6 K (-0.03 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.52 | 900 | 9,468 | 581,797 | 582.7 K to 581.8 K (-0.15 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.51 | 200 | 2,102 | 582,697 | 582.9 K to 582.7 K (-0.03 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Option Exercise | M | 0.39 | 12,500 | 4,875 | 2,445,316 | |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.50 | 400 | 4,200 | 582,897 | 583.3 K to 582.9 K (-0.07 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.49 | 100 | 1,049 | 583,297 | 583.4 K to 583.3 K (-0.02 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.48 | 200 | 2,096 | 583,397 | 583.6 K to 583.4 K (-0.03 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.47 | 100 | 1,047 | 583,597 | 583.7 K to 583.6 K (-0.02 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.46 | 100 | 1,046 | 583,697 | 583.8 K to 583.7 K (-0.02 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.45 | 400 | 4,180 | 583,797 | 584.2 K to 583.8 K (-0.07 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.44 | 1,100 | 11,484 | 584,197 | 585.3 K to 584.2 K (-0.19 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.43 | 200 | 2,086 | 585,297 | 585.5 K to 585.3 K (-0.03 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.42 | 400 | 4,168 | 585,497 | 585.9 K to 585.5 K (-0.07 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.41 | 2,100 | 21,861 | 585,897 | 588 K to 585.9 K (-0.36 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.40 | 1,100 | 11,440 | 587,997 | 589.1 K to 588 K (-0.19 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.39 | 1,500 | 15,585 | 589,097 | 590.6 K to 589.1 K (-0.25 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.38 | 500 | 5,190 | 590,597 | 591.1 K to 590.6 K (-0.08 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.37 | 600 | 6,222 | 591,097 | 591.7 K to 591.1 K (-0.10 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.35 | 400 | 4,140 | 591,697 | 592.1 K to 591.7 K (-0.07 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.34 | 200 | 2,068 | 592,097 | 592.3 K to 592.1 K (-0.03 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.33 | 700 | 7,231 | 592,297 | 593 K to 592.3 K (-0.12 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.32 | 1,400 | 14,448 | 592,997 | 594.4 K to 593 K (-0.24 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.31 | 100 | 1,031 | 594,397 | 594.5 K to 594.4 K (-0.02 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.30 | 1,383 | 14,245 | 594,497 | 595.9 K to 594.5 K (-0.23 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.29 | 1,400 | 14,406 | 595,880 | 597.3 K to 595.9 K (-0.23 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.28 | 1,117 | 11,483 | 597,280 | 598.4 K to 597.3 K (-0.19 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.27 | 1,500 | 15,405 | 598,397 | 599.9 K to 598.4 K (-0.25 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.26 | 1,000 | 10,260 | 599,897 | 600.9 K to 599.9 K (-0.17 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.25 | 100 | 1,025 | 600,897 | 601 K to 600.9 K (-0.02 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.24 | 100 | 1,024 | 600,997 | 601.1 K to 601 K (-0.02 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.22 | 100 | 1,022 | 601,097 | 601.2 K to 601.1 K (-0.02 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.21 | 600 | 6,126 | 601,197 | 601.8 K to 601.2 K (-0.10 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 10.17 | 200 | 2,034 | 601,797 | 602 K to 601.8 K (-0.03 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Buy | M | 0.39 | 12,500 | 4,875 | 601,997 | 589.5 K to 602 K (+2.12 %) |
Jun 01 2007 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | P | 9.17 | 3,500,000 | 32,095,000 | 3,500,000 | 0 to 3.5 M |
May 30 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.46 | 100 | 1,046 | 172,471 | 172.6 K to 172.5 K (-0.06 %) |
May 30 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.33 | 100 | 1,033 | 172,571 | 172.7 K to 172.6 K (-0.06 %) |
May 30 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.32 | 800 | 8,256 | 172,671 | 173.5 K to 172.7 K (-0.46 %) |
May 30 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.31 | 100 | 1,031 | 173,471 | 173.6 K to 173.5 K (-0.06 %) |
May 30 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.31 | 100 | 1,031 | 173,571 | 173.7 K to 173.6 K (-0.06 %) |
May 30 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.31 | 100 | 1,031 | 173,671 | 173.8 K to 173.7 K (-0.06 %) |
May 30 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.30 | 300 | 3,090 | 173,771 | 174.1 K to 173.8 K (-0.17 %) |
May 30 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.30 | 100 | 1,030 | 174,071 | 174.2 K to 174.1 K (-0.06 %) |
May 30 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.29 | 400 | 4,117 | 174,171 | 174.6 K to 174.2 K (-0.23 %) |
May 30 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.29 | 200 | 2,058 | 174,571 | 174.8 K to 174.6 K (-0.11 %) |
May 30 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.28 | 900 | 9,252 | 174,771 | 175.7 K to 174.8 K (-0.51 %) |
May 30 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.27 | 3,900 | 40,053 | 175,671 | 179.6 K to 175.7 K (-2.17 %) |
May 30 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.26 | 6,500 | 66,690 | 179,571 | 186.1 K to 179.6 K (-3.49 %) |
May 30 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 10.25 | 6,400 | 65,600 | 186,071 | 192.5 K to 186.1 K (-3.33 %) |
May 25 2007 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Option Exercise | M | 2.80 | 10,000 | 28,000 | 10,000 | |
May 25 2007 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Option Exercise | M | 4.10 | 12,500 | 51,250 | 20,000 | |
May 25 2007 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Sell | S | 10.20 | 100 | 1,020 | 15,000 | 15.1 K to 15 K (-0.66 %) |
May 25 2007 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Sell | S | 10.21 | 1,100 | 11,231 | 15,100 | 16.2 K to 15.1 K (-6.79 %) |
May 25 2007 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Sell | S | 10.22 | 1,000 | 10,220 | 16,200 | 17.2 K to 16.2 K (-5.81 %) |
May 25 2007 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Sell | S | 10.23 | 1,100 | 11,253 | 17,200 | 18.3 K to 17.2 K (-6.01 %) |
May 25 2007 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Sell | S | 10.24 | 100 | 1,024 | 18,300 | 18.4 K to 18.3 K (-0.54 %) |
May 25 2007 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Sell | S | 10.24 | 700 | 7,168 | 18,400 | 19.1 K to 18.4 K (-3.66 %) |
May 25 2007 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Sell | S | 10.25 | 100 | 1,025 | 19,100 | 19.2 K to 19.1 K (-0.52 %) |
May 25 2007 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Sell | S | 10.25 | 5,562 | 57,011 | 19,200 | 24.8 K to 19.2 K (-22.46 %) |